Protecting Innovation: The Spectre of Trade Secrets Theft in Biotech

5–7 minutes

Trade Secrets theft happens more than you realise

In the fast-paced world of biotechnology, where innovation fuels growth and shapes the future, protecting intellectual property (IP) is paramount. Trade secrets are proprietary processes, formulas, or methods. These give your business its competitive edge. They are among the most valuable assets a biotech company possesses. Yet, they are also among the most vulnerable.

Reflecting on my career, I’ve seen countless examples of trade secrets theft. These experiences highlight the risks faced by even the most sophisticated organisations. In one case, a competitor poached key researchers from an Australian biotech company. This enabled the rapid commercialisation of nearly patent-ready research.

In another instance, an Australian company partnered with an overseas firm to scale its business. They later discovered that their partner had a history of research fraud and IP theft. Perhaps most alarmingly, a principal researcher secretly established an offshore company. They aimed to commercialise their employer’s innovations. This action violated both employment and grant conditions.

These stories aren’t just cautionary tales; they’re a call to action. The risks to trade secrets in Australia’s life sciences sector are significant, but they are not insurmountable. With the right strategies and a proactive approach, companies can protect their innovations and ensure their long-term success.

The Challenges of Protecting Trade Secrets in Australia

The United States, United Kingdom, and European Union have dedicated trade secrets legislation. However, Australia’s legal framework relies heavily on common law. There are laws to criminalise the theft of trade secrets on behalf of foreign governments or their agents. However, these measures are insufficient in deterring determined actors. The complexity and persistence of threats demand more robust protections.

Historically, Australian biotech companies have relied on legal instruments like employment contracts. They also use IP assignments and confidentiality agreements to manage IP risks. While these are necessary, they’re no longer enough to counter sophisticated adversaries. Recognising this, organisations like the Australian Research Council, National Health and Medical Research Council, and the Australian Security Intelligence Organisation have launched initiatives to address these issues. One such initiative is the ‘Protect Your Research’ campaign, which aims to raise awareness and enhance research security.

Despite these efforts, the biotech sector faces unique vulnerabilities. Cyberattacks, insider threats, and accidental disclosures are just some of the ways trade secrets can be compromised. Ill-considered presentations at conferences can also lead to compromise. The rise of remote work and international collaborations has only amplified these risks, creating new entry points for malicious actors.

The Importance of Trade Secrets

Trade secrets are more than just business assets; they are the lifeblood of innovation. They encompass anything from proprietary methods and formulas to draft patents and confidential data. Once a trade secret is compromised, it’s lost forever. Worse still, stolen trade secrets often end up on the dark web. There, they’re brokered between competitors, criminals, and even nation-states.

For biotech companies, the stakes couldn’t be higher. A single breach can derail years of research, jeopardise funding, and tarnish reputations. Protecting trade secrets isn’t just about risk management; it’s about ensuring the survival and growth of the business.

Five Steps to Safeguard Your IP

To combat the specter of trade secrets theft, organisations must take a proactive and comprehensive approach. Here are five key steps every biotech company should consider:

1. Identify Your Trade Secrets

The first step in safeguarding trade secrets is knowing what they are. Conduct a thorough review of your organisation to identify data and processes that meet the trade secret definition. These might include draft patents, proprietary research methods, or experimental data. Once identified, ensure these assets are appropriately labeled, tracked, and protected.

2. Assess the Risks

After identifying your trade secrets, evaluate the risks associated with their exposure. This includes both cybersecurity risks—such as vulnerabilities in IT networks—and physical risks, like the mishandling of prototypes or documents. Don’t forget to consider risks posed by third parties, including suppliers, contract manufacturers, and clinical trial service providers. Develop a risk register to catalog these vulnerabilities and prioritise actions to mitigate them.

3. Foster a Strong Security Culture

People are often the weakest link in any security strategy, but they can also be your greatest asset. Building a strong security culture is essential. This starts with leadership setting the tone and includes ongoing education for employees and suppliers. Ensure that everyone understands what trade secrets are, why they matter, and how to protect them. Regular training, clear communication, and an engaged workforce can significantly reduce insider threats.

4. Develop a Research & Technology Protection Plan (RTP-P)

A Research & Technology Protection Plan serves as a blueprint for safeguarding your intellectual “crown jewels.” It should outline roles and responsibilities, as well as specific controls for cyber, data, workforce, facilities, suppliers, and products. If you don’t have a RTP-P, start small by focusing on high-impact actions. Importantly, an RTP-P shouldn’t be a static document; it needs to be actively implemented and regularly updated.

5. Actively Manage Risks

Protecting trade secrets is not a one-time effort. It requires ongoing attention and adaptability. Assign a dedicated individual or team to oversee trade secret protection. This includes responding to incidents, managing evolving risks, and providing practical recommendations to minimise exposure. Regular reviews and updates are essential to ensure that your strategies remain effective as your business grows and changes.

A Call to Action

In 2024, Australia’s biotech sector is at a critical juncture. As the industry continues to grow and attract international attention, the importance of protecting trade secrets cannot be overstated. Implementing effective systems, processes, and cultural practices is essential for safeguarding IP. It’s also about fostering innovation. It plays a crucial role in attracting investment and securing a competitive edge.

Protecting innovation is everyone’s responsibility. Let’s work together to create a biotech ecosystem where great ideas thrive and remain secure.


So, how prepared is your organisation? Take a moment to evaluate your trade secret protection strategies. Share this article with your team. Begin a discussion about the steps you can take to safeguard your most valuable assets. By prioritising trade secret protection today, you’re investing in the future success of your business and the broader biotech industry.

    Further Reading

    DISCLAIMER: All information presented on paulcurwell.com is intended for general information purposes only. The content of paulcurwell.com should not be considered legal or any other form of advice or opinion on any specific facts or circumstances. Readers should consult their own advisers experts or lawyers on any specific questions they may have. Any reliance placed upon paulcurwell.com is strictly at the reader’s own risk. The views expressed by the authors are entirely their own and do not represent the views of, nor are they endorsed by, their respective employers. Refer here for full disclaimer.